Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Postdoctoral Research Award (CPRA) program

McGill University

$140,000.00

From soma to synapse: imaging selective neuronal vulnerability in presymptomatic Alzheimer's disease

FY 2025-26

Summary
Alzheimer's disease (AD) is a devastating brain disorder marked by two key features: the build-up of toxic proteins and the progressive degeneration of brain cells. However, the accumulation of toxic proteins and the loss of brain cells do not occur throughout the brain all at once. Rather, certain brain cells are affected by toxic proteins before others, leading to early dysfunction and, ultimately, cellular death. Increasing evidence suggests that the cholinergic neurons in the basal forebrain (cBF) and the noradrenergic neurons in the locus coeruleus (nLC) are among the first brain cells to be affected in AD. Despite this, current brain imaging methods lack the sensitivity to detect structural changes in these small brain regions, as well as the specificity to measure their function. To address this gap, we will leverage advanced brain imaging methods to measure both the structural and functional integrity of the cBF and nLC in cognitive normal older adults at risk for AD. Specifically, we will examine whether structural and functional measures of these cellular systems can differentiate individuals at varying levels of AD risk. We will also investigate whether structural alterations parallel changes in cellular function within individuals. Overall, the proposed work will provide the most comprehensive assessment to date of the brain's most vulnerable cells in the earliest stages of AD. In turn, these results will lay the groundwork for improved early detection strategies and targeted therapies for AD prevention and treatment.
Program
Canada Postdoctoral Research Award (CPRA) program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
536858
Name
Onuska Kate M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
From soma to synapse: imaging selective neuronal vulnerability in presymptomatic Alzheimer's disease
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Alzheimer'S Disease; Cholinergic Basal Forebrain; Imaging Biomarkers; Multiparametric Quantitative Magnetic Resonance Imaging; Noradrenergic Locus Coeruleus; Pathology; Positron Emission Tomography; Selective Neuronal Vulnerability
Abstract
Alzheimer's disease (AD) is a devastating brain disorder marked by two key features: the build-up of toxic proteins and the progressive degeneration of brain cells. However, the accumulation of toxic proteins and the loss of brain cells do not occur throughout the brain all at once. Rather, certain brain cells are affected by toxic proteins before others, leading to early dysfunction and, ultimately, cellular death. Increasing evidence suggests that the cholinergic neurons in the basal forebrain (cBF) and the noradrenergic neurons in the locus coeruleus (nLC) are among the first brain cells to be affected in AD. Despite this, current brain imaging methods lack the sensitivity to detect structural changes in these small brain regions, as well as the specificity to measure their function. To address this gap, we will leverage advanced brain imaging methods to measure both the structural and functional integrity of the cBF and nLC in cognitive normal older adults at risk for AD. Specifically, we will examine whether structural and functional measures of these cellular systems can differentiate individuals at varying levels of AD risk. We will also investigate whether structural alterations parallel changes in cellular function within individuals. Overall, the proposed work will provide the most comprehensive assessment to date of the brain's most vulnerable cells in the earliest stages of AD. In turn, these results will lay the groundwork for improved early detection strategies and targeted therapies for AD prevention and treatment.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Onuska, Kate M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
McGill University - $140,000 Grant (2025-26) | Canada Spends